Activated Wnt/β-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model

Andy J. Chien, Erin C. Moore, Anke S. Lonsdorf, Rima M. Kulikauskas, Bonnie Gould Rothberg, Aaron J. Berger, Michael B. Major, Samuel T Hwang, David L. Rimm, Randall T. Moon

Research output: Contribution to journalArticle

220 Citations (Scopus)

Abstract

This study demonstrates that in malignant melanoma, elevated levels of nuclear β-catenin in both primary tumors and metastases correlate with reduced expression of a marker of proliferation and with improved survival, in contrast to colorectal cancer. The reduction in proliferation observed in vivo is recapitulated in B16 murine melanoma cells and in human melanoma cell lines cultured in vitro with either WNT3A or small-molecule activators of β-catenin signaling. Consistent with these results, B16 melanoma cells expressing WNT3A also exhibit decreased tumor size and decreased metastasis when implanted into mice. Genome-wide transcriptional profiling reveals that WNT3A up-regulates genes implicated in melanocyte differentiation, several of which are down-regulated with melanoma progression. These findings suggest that WNT3A can mediate transcriptional changes in melanoma cells in a manner reminiscent of the known role of Wnt/β-catenin signaling in normal melanocyte development, thereby altering melanoma cell fate to one that may be less proliferative and potentially less aggressive. Our results may explain the observed loss of nuclear β-catenin with melanoma progression in human tumors, which could reflect a dysregulation of cellular differentiation through a loss of homeostatic Wnt/β-catenin signaling.

Original languageEnglish (US)
Pages (from-to)1193-1198
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume106
Issue number4
DOIs
StatePublished - Jan 27 2009
Externally publishedYes

Fingerprint

Catenins
Melanoma
Neoplasms
Experimental Melanomas
Melanocytes
Neoplasm Metastasis
Colorectal Neoplasms
Up-Regulation
Genome
Cell Line
Survival
Genes

Keywords

  • B16 model
  • Differentiation
  • Metastasis
  • Microarray
  • Prognosis
  • WNT5A

ASJC Scopus subject areas

  • General

Cite this

Activated Wnt/β-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model. / Chien, Andy J.; Moore, Erin C.; Lonsdorf, Anke S.; Kulikauskas, Rima M.; Rothberg, Bonnie Gould; Berger, Aaron J.; Major, Michael B.; Hwang, Samuel T; Rimm, David L.; Moon, Randall T.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 106, No. 4, 27.01.2009, p. 1193-1198.

Research output: Contribution to journalArticle

Chien, Andy J. ; Moore, Erin C. ; Lonsdorf, Anke S. ; Kulikauskas, Rima M. ; Rothberg, Bonnie Gould ; Berger, Aaron J. ; Major, Michael B. ; Hwang, Samuel T ; Rimm, David L. ; Moon, Randall T. / Activated Wnt/β-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model. In: Proceedings of the National Academy of Sciences of the United States of America. 2009 ; Vol. 106, No. 4. pp. 1193-1198.
@article{954dcc232ab044ddadf9120eb2cdfa88,
title = "Activated Wnt/β-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model",
abstract = "This study demonstrates that in malignant melanoma, elevated levels of nuclear β-catenin in both primary tumors and metastases correlate with reduced expression of a marker of proliferation and with improved survival, in contrast to colorectal cancer. The reduction in proliferation observed in vivo is recapitulated in B16 murine melanoma cells and in human melanoma cell lines cultured in vitro with either WNT3A or small-molecule activators of β-catenin signaling. Consistent with these results, B16 melanoma cells expressing WNT3A also exhibit decreased tumor size and decreased metastasis when implanted into mice. Genome-wide transcriptional profiling reveals that WNT3A up-regulates genes implicated in melanocyte differentiation, several of which are down-regulated with melanoma progression. These findings suggest that WNT3A can mediate transcriptional changes in melanoma cells in a manner reminiscent of the known role of Wnt/β-catenin signaling in normal melanocyte development, thereby altering melanoma cell fate to one that may be less proliferative and potentially less aggressive. Our results may explain the observed loss of nuclear β-catenin with melanoma progression in human tumors, which could reflect a dysregulation of cellular differentiation through a loss of homeostatic Wnt/β-catenin signaling.",
keywords = "B16 model, Differentiation, Metastasis, Microarray, Prognosis, WNT5A",
author = "Chien, {Andy J.} and Moore, {Erin C.} and Lonsdorf, {Anke S.} and Kulikauskas, {Rima M.} and Rothberg, {Bonnie Gould} and Berger, {Aaron J.} and Major, {Michael B.} and Hwang, {Samuel T} and Rimm, {David L.} and Moon, {Randall T.}",
year = "2009",
month = "1",
day = "27",
doi = "10.1073/pnas.0811902106",
language = "English (US)",
volume = "106",
pages = "1193--1198",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "4",

}

TY - JOUR

T1 - Activated Wnt/β-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model

AU - Chien, Andy J.

AU - Moore, Erin C.

AU - Lonsdorf, Anke S.

AU - Kulikauskas, Rima M.

AU - Rothberg, Bonnie Gould

AU - Berger, Aaron J.

AU - Major, Michael B.

AU - Hwang, Samuel T

AU - Rimm, David L.

AU - Moon, Randall T.

PY - 2009/1/27

Y1 - 2009/1/27

N2 - This study demonstrates that in malignant melanoma, elevated levels of nuclear β-catenin in both primary tumors and metastases correlate with reduced expression of a marker of proliferation and with improved survival, in contrast to colorectal cancer. The reduction in proliferation observed in vivo is recapitulated in B16 murine melanoma cells and in human melanoma cell lines cultured in vitro with either WNT3A or small-molecule activators of β-catenin signaling. Consistent with these results, B16 melanoma cells expressing WNT3A also exhibit decreased tumor size and decreased metastasis when implanted into mice. Genome-wide transcriptional profiling reveals that WNT3A up-regulates genes implicated in melanocyte differentiation, several of which are down-regulated with melanoma progression. These findings suggest that WNT3A can mediate transcriptional changes in melanoma cells in a manner reminiscent of the known role of Wnt/β-catenin signaling in normal melanocyte development, thereby altering melanoma cell fate to one that may be less proliferative and potentially less aggressive. Our results may explain the observed loss of nuclear β-catenin with melanoma progression in human tumors, which could reflect a dysregulation of cellular differentiation through a loss of homeostatic Wnt/β-catenin signaling.

AB - This study demonstrates that in malignant melanoma, elevated levels of nuclear β-catenin in both primary tumors and metastases correlate with reduced expression of a marker of proliferation and with improved survival, in contrast to colorectal cancer. The reduction in proliferation observed in vivo is recapitulated in B16 murine melanoma cells and in human melanoma cell lines cultured in vitro with either WNT3A or small-molecule activators of β-catenin signaling. Consistent with these results, B16 melanoma cells expressing WNT3A also exhibit decreased tumor size and decreased metastasis when implanted into mice. Genome-wide transcriptional profiling reveals that WNT3A up-regulates genes implicated in melanocyte differentiation, several of which are down-regulated with melanoma progression. These findings suggest that WNT3A can mediate transcriptional changes in melanoma cells in a manner reminiscent of the known role of Wnt/β-catenin signaling in normal melanocyte development, thereby altering melanoma cell fate to one that may be less proliferative and potentially less aggressive. Our results may explain the observed loss of nuclear β-catenin with melanoma progression in human tumors, which could reflect a dysregulation of cellular differentiation through a loss of homeostatic Wnt/β-catenin signaling.

KW - B16 model

KW - Differentiation

KW - Metastasis

KW - Microarray

KW - Prognosis

KW - WNT5A

UR - http://www.scopus.com/inward/record.url?scp=59049101982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59049101982&partnerID=8YFLogxK

U2 - 10.1073/pnas.0811902106

DO - 10.1073/pnas.0811902106

M3 - Article

C2 - 19144919

AN - SCOPUS:59049101982

VL - 106

SP - 1193

EP - 1198

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 4

ER -